Perrigo Initiates Nationwide Voluntary Product Recall of Acetaminophen Infant Suspension Liquid, 160 mg/5 mL, Due to a Potential Defect with the Co-packaged Oral Syringe

The Perrigo Company (NYSE: PRGO; TASE) announced today that it has initiated a voluntary, nationwide product recall to the retail level of 18 batches of its acetaminophen infant suspension liquid, 160 mg/5 mL, sold in 2 oz. and 4 oz. bottles with syringes in a box under the store brand products listed below. The recall is being initiated because of the remote potential that a small number of packages might contain an oral dosing syringe without dose markings.